Western blot
0.2-1 ug/mlPositive Control: Human Muscle| Product Name | Rabbit anti-LFNG polyclonal antibody - N-terminal region |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SCDO3 |
| Immunogen | The immunogen for anti-LFNG antibody: synthetic peptide directed towards the N terminal of human LFNG |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | BovineHumanMouseRabbitRat |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | LFNG |
|---|---|
| Gene Synonyms | SCDO3 |
| Gene Full Name | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
| Gene Summary | LFNG is a member of the glycosyltransferase superfamily. It is a single-pass type II Golgi membrane protein that functions as a fucose-specific glycosyltransferase, adding an N-acetylglucosamine to the fucose residue of a group of signaling receptors involved in regulating cell fate decisions during development. Mutations in the gene that encodes this protein have been associated with autosomal recessive spondylocostal dysostosis 3. This gene encodes a member of the glycosyltransferase superfamily. The encoded protein is a single-pass type II Golgi membrane protein that functions as a fucose-specific glycosyltransferase, adding an N-acetylglucosamine to the fucose residue of a group of signaling receptors involved in regulating cell fate decisions during development. Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. Alternatively spliced transcript variants that encode different isoforms have been described, however, not all variants have been fully characterized. |
| Alternative Names | SCDO3 |
| Molecular Weight(MW) | 39kDa |
| Sequence | 361 amino acids |
| Entrez Gene | 3955 |
|---|---|
| SwissProt ID | Q8NES3-3 |
| Protein Accession | NP_001035258 |
Western blot
0.2-1 ug/mlPositive Control: Human Muscle| Application Notes | WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
